Probiotics in the management of gastrointestinal disease: Analysis of the attitudes and prescribing practices of gastroenterologists and surgeons

Journal of Digestive Diseases

Volumn 12, Issue 6, 2011, Pages 489-496

  Cordina, Claire ^a   Shaikh, Irshad ^b   Shrestha, Sussie ^c   Camilleri Brennan, John ^c  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c Stirling Royal Infirmary   (United Kingdom)

Author keywords

Gastroenterology; Gastrointestinal disorder; Prescribing practice; Probiotic; Surgery

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ARTICLE; BEVERAGE; CROHN DISEASE; DIET SUPPLEMENTATION; GASTROINTESTINAL DISEASE; HUMAN; ILEITIS; IRRITABLE COLON; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT INDICATION; ULCERATIVE COLITIS; UNITED KINGDOM;

ATTITUDE OF HEALTH PERSONNEL; COLITIS, ULCERATIVE; CROHN DISEASE; DATA COLLECTION; DIARRHEA; DISEASE MANAGEMENT; GASTROINTESTINAL DISEASES; GREAT BRITAIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PROBIOTICS; QUESTIONNAIRES; TIME FACTORS;

EID: 82355169240     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00534.x     Document Type: Article

References (42)

1. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, Ontario, Canada. Guidelines for the Evaluation of Probiotics in Food. April 30 and May 1, 2002. Cited 18 September 2011. Available from URL:
2. Gupta V, Garg R. Probiotics. Indian Med Microbiol 2009; 27: 202-9.
3. Sharp RR, Achkar JP, Brinich MA, Farrell RM. Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol 2009; 104: 809-13.
4. Lammers KM, Helwig U, Swennen E etal. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 2002; 97: 1182-6.
5. O'Hara AM, O'Regan P, Fanning A etal. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006; 118: 202-15.
6. Otte JM, Podolsky DK. Functional modulation of enterocytes by gram positive and gram negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004; 286: G613-626.
7. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 2007; 75: 2399-407.
8. Hart AL, Lammers K, Brigidi P etal. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53: 1602-9.
9. Stagg AJ, Hart AL, Knight SC, Kamm MA. Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract Res Clin Gastroenterol 2004; 18: 255-70.
10. Madsen K, Cornish A, Soper P etal. Probiotic bacteria enhance murine and human intestinal barrier function. Gastroenterologica 2001; 121: 580-91.
11. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002; 18: 586-90.
12. Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007; 292: G315-322.
13. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-950.
14. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12: 221-37.
15. Pothoulakis C, Kelly CP, Joshi MA etal. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-15.
16. Naaber P, Mikelsaar M. Interactions between lactobacilli and antibiotic-associated diarrhoea. Adv Appl Microbiol 2004; 54: 231-60.
17. Trejo FM, Minnaard J, Perez PF, De Antoni GL. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006; 12: 186-93.
18. Miller M. The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy. Anaerobe 2009; 15: 281-4.
19. Directory of Gastroenterology. Ashstead: Mediahuset, 2009.
20. Dr Foster Research Ltd. Consultant Guide. Cited 25 September 2011. Available from URL .
21. Masco L, Huys G, De Brandt E, Temmerman R, Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005; 102: 221-30.
22. Jayamanne VS, Adams MR. Determination of survival, identity and stress resistance of probiotic bifidobacteria in bio-yoghurts. Lett Appl Microbiol 2006; 42: 189-94.
23. Marcobal A, Underwood MA, Mills DA. Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis. J Pediatr Gastroenterol Nutr 2008; 46: 608-11.
24. Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999; 2: 223-9.
25. Temmerman R, Masco L, Vanhoutte T, Huys G, Swings J. Development and validation of a nested-PCR-denaturing gradient gel electrophoresis method for taxonomic characterisation of bifidobacterial communities. Appl Environ Microbiol 2003; 69: 6380-5.
26. Quigley EM. Probiotics in functional gastrointestinal disorders: what are the facts? Curr Opin Pharmacol 2008; 8: 704-8.
27. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9: 15.
28. Moayyedi P, Ford AC, Talley NJ etal. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-32.
29. Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol 2010; 300: 25-33.
30. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2006; 4 Art. No.: CD004826. DOI: 10.1002/14651858.CD004826.pub2.
31. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45: 1462-4.
32. Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008; 3 Art. No.: CD006634. DOI: 10.1002/14651858.CD006634.pub2.
33. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009; 4 Art. No.: CD006873. DOI: 10.1002/14651858.CD006873.pub2.
34. Mallon PT, Mckay D, Kirk SJ, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 4 Art. No.: CD005573. DOI: 10.1002/14651858.CD005573.pub2.
35. Gionchetti P, Rizzello F, Venturi A etal. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterologica 2000; 119: 305-9.
36. Gionchetti P, Rizzello F, Helwig U etal. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterologica 2003; 124: 1202-9.
37. Guarner F, Khan, AG, Garisch, J etal. 2008 World Gastroenterology Organisation Practice Guideline. Probiotics and Prebiotics. Cited: 18 September 2011, Available from URL: .
38. Pillai A, Nelson RL. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 2008; (1) Art. No.: CD004611. DOI: 10.1002/14651858.CD004611.pub2.
39. Mcfarland LV, Surawicz CM, Greenberg RN etal. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271: 1913-18.
40. Hickson M, D'Souza AL, Muthu N etal. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomized double-blind placebo-controlled trial. BMJ 2007; 335: 80-3.
41. Wilcox MH, Sandoe JA. Probiotics and diarrhoea: data are not widely applicable. BMJ 2007; 335: 171.
42. Johnston BC, Thorlund K. Probiotics for the prevention of Clostridium difficile associated diarrhoea in adults and children. Cochrane Database Syst Rev 2009; 1. Cited 18 September 2011. Available from URL: .